Key statistics · As on 15 Nov 2026
Market cap
BDT 6,810.188 mn
Free float market cap
BDT 2,375.329 mn
NAV per share
BDT 45.29
P/E (audited)
13.88x
Day's value
BDT 15.27 mn
Day's volume
241,614
Day's trades
463
Volume Weighted Average Price (VWAP)
BDT 63.20
Opening price
BDT 63.80
Adjusted Opening Price
BDT 63.40
Yesterday's closing price
BDT 63.40
Closing price
—
Last Update
1:02 PM
Day's range
Current BDT 63.00
BDT 62.90BDT 63.80
52-week range
Current BDT 63.00
BDT 45.50BDT 78.00
Basics
- Listing year
- 2022
- Authorized Capital (mn)
- BDT 2,000
- Paid-up capital
- BDT 1,074.16 mn
- Face value
- BDT 10.00
- Total outstanding securities
- 107,416,217
- Market Lot
- 1
Shareholding pattern
as on Jun 28, 2025 (year ended)
as on Sep 30, 2026
as on Oct 31, 2026
Sponsor / Director
31.64%
31.64%
31.64%
Government
0.00%
0.00%
0.00%
Institution
9.42%
11.11%
11.26%
Foreign
19.63%
19.63%
19.63%
Public
39.31%
37.62%
37.47%
Shareholding percentages as reported by the listed company.
Sponsor/Director holdings reflect regulation 2(1)(r) of the DSE (Listing) Regulations 2015.
Corporate & contact
- Present Operational Status
- Active
- Head Office / Registered Office
- 99 Gulshan Avenue, Rupayan Golden Age, 6th Floor, Plot-6, Block-CWN(C), Dhaka-1212
- Factory Address
- 1071, 1073, North Rupshi, Tarabo Municipality, Rupganj, Narayanganj.
- Contact Phone
- 880-2-55033580-3
- Fax
- 880-2-55033579
- cs@navanapharma.com
- Company Secretary Name
- Lorens Shamol Mollick FCS
- Company Secretary Cell No.
- 01321 131222
- Company Secretary Telephone No.
- 02-55033580-3
- Company Secretary E-mail
- secretary@navanapharma.com
- Website
- www.navanapharma.com
- Loan status
- Short-term: BDT 51.82 mn · Long-term: BDT 11.02 mn
- Present Loan Status — as on
- —
- Credit rating
- Short-term: — · Long-term: —
- Last AGM
- 31-12-2025
- Year-end
- June
Details of Financial Statementhttps://navanapharma.com/page/audited-accounts
Price Sensitive Informationhttps://navanapharma.com/page/psi